Institut Bergonié breast cancer database
Bergonie Institute Breast Cancer Database
This project collects clinical and treatment information from adults treated for breast cancer at Institut Bergonié to see if patient and disease factors relate to survival and outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30000 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Institut Bergonié Academic / other |
| Locations | 1 site (Bordeaux) |
| Trial ID | NCT02893761 on ClinicalTrials.gov |
What this trial studies
The registry compiles clinical, pathological, treatment, and follow-up data on adults diagnosed with breast cancer who received their first treatment at Institut Bergonié, with records dating back to the 1990s and ongoing enrollment. Data are abstracted from medical records and linked to survival outcomes to describe practice patterns and to search for prognostic factors. The database is observational and supports descriptive analyses and hypothesis generation rather than testing a specific therapy. Data are used for institutional quality assessment and research into factors that influence long-term outcomes.
Who should consider this trial
Good fit: Adults aged 18 and over with a diagnosis of breast cancer who received their first treatment at Institut Bergonié are the intended participants.
Not a fit: People under 18, those without breast cancer, or patients treated entirely at other hospitals would not be included and are unlikely to benefit directly from this database.
Why it matters
Potential benefit: If successful, the database could help clinicians identify factors linked to better or worse survival and guide improvements in care over time.
How similar studies have performed: Other hospital and population-based breast cancer registries have successfully identified prognostic factors and informed care, so this local database follows a proven approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Breast cancer * Aged 18 years and over * First treatment at Bergonie Institute Exclusion Criteria: \-
Where this trial is running
Bordeaux
- Institut Bergonié, Comprehensive Cancer Center — Bordeaux, France (Recruiting)
Study contacts
- Principal investigator: Gaetan Mac Grogan, MD — Institut Bergonié
- Study coordinator: Gaetan Mac Grogan, MD
- Email: g.macgrogan@bordeaux.unicancer.fr
- Phone: + 33 5 56 33 33 33
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.